Hydrogen-related enhancement of in vivo antioxidant ability in the brain of rats fed coral calcium hydride.
Ueda Y, Nakajima A, Oikawa T. · 2010
Research-use notice
Independent study record
Each H2HUBB study page organizes source-linked research details for educational use. Interpretation should remain proportional to the study design, population, controls, and limitations.
H2HUBB TAKEAWAY
The study identified a possible biological mechanism for hydrogen rather than demonstrating a clinical treatment effect.
Molecular hydrogen oral health study 2010 ueda: what the findings mean
This H2HUBB page translates the technical study record into consumer-friendly language while preserving the scientific details. This animal study examined Hydrogen-related enhancement of in vivo antioxidant ability in the brain of rats fed coral calcium hydride. The abstract describes Rat model; reported duration 4 weeks. These results clarify the mechanism that CCH may exert antioxidant activity by significantly enhancing the basal endogenous antioxidant ability in the hippocampus through a….
How to read this paper: This is a mechanism-focused study. It investigates a biological target or pathway through which molecular hydrogen may act; it does not establish clinical benefit in people.
Publication: Ueda Y, Nakajima A, Oikawa T., 2010.
What the researchers studied
The researchers examined how molecular hydrogen related to dental and oral health. The available structured record did not clearly identify one primary outcome, so the original source should be checked for the complete endpoint definitions.
What effects did molecular hydrogen have?
Observed mechanistic effect: These results clarify the mechanism that CCH may exert antioxidant activity by significantly enhancing the basal endogenous antioxidant ability in the hippocampus through a… This study explored the effect of coral calcium hydride (CCH) on rat intrahippocampal antioxidant ability by measuring the PCAM nitroxide radical decay ratio when CCH was (a) co-perfused into the hippocampus and (b) fed orally to the rats for 4 weeks under a freely moving state. The finding identifies a possible biological target or pathway through which molecular hydrogen may act. It does not establish clinical benefit in people.
Why these findings matter
This research helps explain how hydrogen may act at a biological level. It strengthens the scientific rationale for future therapeutic studies, but it does not show that patients will experience a clinical benefit.
How strong is this evidence?
This is preclinical animal evidence. It can show biological effects in a whole living system, but human effectiveness and dosing still require clinical trials. Comparison or control: Control group reported.
Conservative interpretation: A biological mechanism can strengthen scientific plausibility, but it does not establish clinical benefit, effective dosing, or safety in patients.
Technical study details
- Publication type: Animal study
- Evidence type: Preclinical animal evidence
- Research model or population: Rat model
- Control or comparison: Control group reported
- Hydrogen method: Other or not reported
- Treatment duration: 4 weeks
Limitations and safety
Important limitations: Preclinical animal findings may not translate directly to human outcomes.
Safety information: The abstract did not provide detailed safety or adverse-event information.
Original study and H2HUBB research context
This page explains a published research record and does not turn one study into a medical recommendation. Read the original scientific source for the complete methods, statistics, and author conclusions. Compare this result with related evidence in the H2HUBB Molecular Hydrogen Research Library.